Researchers from both teams plan to continue to refine their findings toward creating simple PCR or other nucleic acid amplification-based assays.
The company also cut its net loss in the first half of the year to €6.7 million from €12.4 million in the year-ago period.
CombiMatrix said the move will increase access to the test in the state for women experiencing recurrent pregnancy loss.
A renal cell carcinoma study revealed increased metabolic gene expression in PD-L1-positive tumors from individuals who did not respond to nivolumab.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.
The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.
An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.
In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.